Melphalan hydrochloride
Melphalan Hydrochloride is a prescription injectable chemotherapy drug administered intravenously, available in a 50 mg vial strength. It's manufactured by companies like Gland Pharma Limited and Sagent Pharmaceuticals under FDA approval ANDA209826. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Melphalan Hydrochloride is a prescription injectable chemotherapy drug administered intravenously, available in a 50 mg vial strength. It's manufactured by companies like Gland Pharma Limited and Sagent Pharmaceuticals under FDA approval ANDA209826. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Melphalan hydrochloride", "mediaType": "text/html", "description": " Access the FDA dataset for Melphalan hydrochloride — ANDA 203655 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203655" } ] |
| identifier | ANDA203655 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "medications", "pharmaceuticals", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Melphalan hydrochloride |
